Güler Günnur, Acikgoz Eda, Mukhtarova Günel, Oktem Gulperi
Biophysics Laboratory, Department of Physics, Izmir Institute of Technology, Urla, 35433, Izmir, Turkey.
Department of Histology and Embryology, Faculty of Medicine, Van Yuzuncu Yil University, 65080, Van, Turkey.
Arch Biochem Biophys. 2024 Mar;753:109920. doi: 10.1016/j.abb.2024.109920. Epub 2024 Feb 1.
Revealing the potential of candidate drugs against different cancer types without disrupting normal cells depends on the drug mode of action. In the current study, the drug response of prostate cancer stem cells (PCSCs) to zoledronic acid (ZOL) grown in two-dimensional (2D) and three-dimensional (3D) culture systems was compared using Fourier transform-infrared (FT-IR) spectroscopy which is a vibrational spectroscopic technique, supporting by biochemical assays and imaging techniques. Based on our data, in 2D cell culture conditions, the ZOL treatment of PCSCs isolated according to both C133 and CD44 cell surface properties induced early/late apoptosis and suppressed migration ability. The CD133 gene expression and protein levels were altered, depending on culture systems. CD133 expression was significantly reduced in 2D cells upon ZOL treatment. FT-IR data revealed that the integrity, fluidity, and ordering/disordering states of the cell membrane and nucleic acid content were altered in both 2D and 3D cells after ZOL treatment. Regular protein structures decrease in 2D cells while glycogen and protein contents increase in 3D cells, indicating a more pronounced cytotoxic effect of ZOL for 2D cells. Untreated 3D PCSCs exhibited an even different spectral profile associated with IR signals of lipids, proteins, nucleic acids, and glycogen in comparison to untreated 2D cells. Our study revealed significant differences in the drug response and cellular constituents between 2D and 3D cells. Exploring molecular targets and/or drug-action mechanisms is significant in cancer treatment approaches; thus, FT-IR spectroscopy can be successfully applied as a novel drug-screening method in clinical research.
在不破坏正常细胞的情况下揭示候选药物对不同癌症类型的潜力取决于药物的作用方式。在当前研究中,使用傅里叶变换红外(FT-IR)光谱法(一种振动光谱技术),并辅以生化分析和成像技术,比较了前列腺癌干细胞(PCSCs)在二维(2D)和三维(3D)培养系统中生长时对唑来膦酸(ZOL)的药物反应。根据我们的数据,在2D细胞培养条件下,根据C133和CD44细胞表面特性分离的PCSCs经ZOL处理后诱导早期/晚期凋亡并抑制迁移能力。CD133基因表达和蛋白水平根据培养系统而改变。ZOL处理后,2D细胞中的CD133表达显著降低。FT-IR数据显示,ZOL处理后,2D和3D细胞中细胞膜的完整性、流动性以及有序/无序状态和核酸含量均发生了改变。2D细胞中规则的蛋白质结构减少,而3D细胞中糖原和蛋白质含量增加,这表明ZOL对2D细胞的细胞毒性作用更为明显。与未处理的2D细胞相比,未处理的3D PCSCs表现出与脂质、蛋白质、核酸和糖原的红外信号相关的甚至不同的光谱特征。我们的研究揭示了2D和3D细胞在药物反应和细胞成分方面的显著差异。探索分子靶点和/或药物作用机制在癌症治疗方法中具有重要意义;因此,FT-IR光谱法可作为一种新型药物筛选方法成功应用于临床研究。